Therapeutics
-
Biologics
Silver Bullet Therapeutics Reports Results of OrthoFuzIon® Antimicrobial Bone Screw Testing Against the Top Six CDC Antibiotic Resistant “Superbugs”1
November 03, 2016 SAN JOSE, Calif.–(BUSINESS WIRE)–Silver Bullet Therapeutics, Inc., a privately held medical device company that has developed an…
Read More » -
Biologics
InVivo Therapeutics Announces Appointment of Jeffrey Hatfield to Board of Directors
November 02, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Jeffrey Hatfield to its Board of…
Read More » -
Biologics
InVivo Therapeutics Announces Foothills Medical Centre in Calgary, Alberta as New Canadian Site for INSPIRE Study
October 19, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Foothills Medical Centre in Calgary, Alberta has…
Read More » -
Biologics
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has appointed R. Alberto Avendano, M.D., as the Company’s…
Read More » -
Biologics
Carmell Therapeutics New Management Team
PITTSBURGH, Oct. 5, 2016 /PRNewswire/ — Carmell Therapeutics, a biosurgical technology company focused on the development and commercialization of innovative plasma-based bioactive materials,…
Read More » -
Extremities
Flexion Therapeutics Announces Appointment of John Magee as Vice President of Sales
BURLINGTON, Mass., Sept. 29, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc.(Nasdaq:FLXN) announced today that it has appointed John Magee as…
Read More » -
Biologics
InVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting
September 07, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Kristin Neff, Vice President of Clinical Operations &…
Read More » -
Financial
Cesca Therapeutics Announces Conversion of $12.5 Million in Senior Secured Debt to Equity
RANCHO CORDOVA, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today…
Read More » -
Neuro
InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™
August 17, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the ninth patient implanted with the Neuro-Spinal Scaffold™…
Read More » -
Neuro
Pamela Stahl appointed chief commercial officer of InVivo Therapeutics
15th August 2016 InVivo Therapeutics Holdings has appointed Pamela Stahl to the newly-created position of chief commercial officer, effective September…
Read More » -
Financial
InVivo Therapeutics Q2 meets the street, shares stay steady
August 5, 2016 – By FINK DENSFORD InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met…
Read More » -
Financial
Flexion Therapeutics Reports Second-Quarter 2016 Financial Results
BURLINGTON, Mass., Aug. 03, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced financial results for the second quarter…
Read More » -
Financial
Anika Reports Second Quarter 2016 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its…
Read More » -
Biologics
InVivo Therapeutics Announces Ben Taub Hospital/Baylor College of Medicine as New Site for INSPIRE Study
July 18, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Ben Taub Hospital in Houston, TX…
Read More » -
Recon
Flexion Therapeutics Adds Three New Executives in Key Roles to Support the Planned Commercial Launch of Zilretta™
BURLINGTON, Mass., July 06, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that three new executives have joined…
Read More »